PXD034644 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | N-acetylcysteine overcomes NF1-loss driven resistance to PI3K alpha inhibition in breast cancer. |
Description | Breast cancer is the second most common cancer type worldwide, representing 25% of all cancers in women. PIK3CA is one of the most frequently mutated genes in breast cancer and mutations result in constitutive activation of the PI3K/mTOR pathway. More than 30 inhibitors against PI3K/mTOR are being tested in clinical trials, however, resistance mechanisms evolve frequently resulting in disease progression. The aim of our study was to investigate PIK3CA collaborative mutations that result in resistance to BYL719, a PI3Kα selective inhibitor. For this purpose, we used a genome-wide PiggyBac transposon mediated mutagenesis screen in a PIK3CAH1047R mutated murine tumor model. One of the tumor suppressor genes discovered was neurofibromin 1 (NF1). Using shRNA-mediated knockdown and CRISPR/Cas9-mediated knockout of NF1 in murine and human PIK3CAH1047R cell lines and a patient derived xenograft organoid model, we found that NF1 loss reduces sensitivity to PI3Kα inhibition. Additionally, we find that loss of NF1 correlates with enhanced glycolysis and lower levels of ROS. Unexpectedly, treatment with NAC sensitized NF1 KO cells to PI3K inhibition in vitro, and in vivo. Global phospho-proteomics indicated that the combination with NAC enhances the inhibitory effect of PI3K inhibition on mTOR signaling, which inhibits proliferation of NF1 KO tumor cells. This raises the interesting possibility to combine PI3K inhibition with NAC especially in NF1 loss tumors |
HostingRepository | PRIDE |
AnnounceDate | 2024-10-07 |
AnnouncementXML | Submission_2024-10-07_11:06:25.039.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Katarzyna Buczak |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | phosphorylated residue; iodoacetamide derivatized residue |
Instrument | Orbitrap Fusion Lumos |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2022-06-19 04:58:32 | ID requested | |
⏵ 1 | 2024-10-07 11:06:25 | announced | |
Publication List
Dataset with its publication pending |
Keyword List
submitter keyword: TMT,PI3K alpha inhibition, phospho proteomics,Breast cancer |
Contact List
Alexander Schmidt |
contact affiliation | Proteomics Core Facillity, Biozentrum, University of Basel 4056 Basel, Switzerland |
contact email | alex.schmidt@unibas.ch |
lab head | |
Katarzyna Buczak |
contact affiliation | Biozentrum, University of Basel |
contact email | katarzyna.buczak@unibas.ch |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2023/03/PXD034644 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD034644
- Label: PRIDE project
- Name: N-acetylcysteine overcomes NF1-loss driven resistance to PI3K alpha inhibition in breast cancer.